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Miller and colleagues1 report on the within- and cross-condition recurrence of later born siblings of 
children (‘probands’) with attention deficit/hyperactivity disorder (ADHD) or autism spectrum 
disorder (ASD).  The relatively high heritability of both conditions is well established from twin 
studies assessing both trait variance2 and diagnostic recurrence3.  Two recent large-scale 
Scandinavian studies extended this work to show that the two conditions also run together in 
families.  One population-based study of children with ASD (n=3,578) estimated the combined 
(older and younger) sibling recurrence of ASD to be 10.5% but also reported that 5.3% had siblings 
with a diagnosis of ADHD, giving relative risks of 11.8 and 3.7 compared to matched controls 
without ASD4.  An even larger population registry study with n=28,468 cases of ASD found that 
full siblings had a similarly elevated odds ratio of 4.59 of having an ADHD diagnosis compared to 
siblings of individuals without an ASD diagnosis5.  This familial cross-aggregation between the two 
conditions highlights the importance both of providing clinically useful estimates of elevated likely 
recurrence rates and of studying shared neurodevelopmental paths to the two conditions6. 
 
Although the US medical records data reported by Miller et al1 is more modest in scale than these 
large Scandinavian population studies it does speak very directly to a question of clinical concern.  
When parents are told by clinicians that their child has a diagnosis of a neurodevelopmental 
condition such as ASD or ADHD, one important question – often asked by parents themselves – is 
“What are the chances that my younger/future children will have ASD or ADHD?”.  To answer this 
question, we need to know the recurrence rates for later born siblings; the question directly 
addressed in the current study.  Miller and colleagues1 report that 12.03% of later born siblings of 
older probands with ASD also went on to have a diagnosis of ASD themselves (an elevated odds 
ratio of 30.38 compared to later born siblings of children without an ASD diagnosis).  However, 
later born siblings of probands with ASD also had an elevated likelihood of an ADHD diagnosis 
(3.80%; odds ratio 3.7).  Conversely, for later born siblings of probands with an ADHD diagnosis 
the within-condition recurrence rate for ADHD was 12.47% (odds ratio compared to later born 
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siblings of children without an ADHD diagnosis 13.05) and the cross-condition recurrence rate for 
ASD was 1.92% (odds ratio 4.35).  This is likely if anything to be an underestimate, since children 
with a diagnosis of both ASD and ADHD were placed in the ASD group. 
 
These within- and cross-condition recurrence figures are of important clinical utility in terms of 
informing discussions with parents about the need for enhanced developmental surveillance for 
neurodevelopmental conditions such as ASD and ADHD in their younger children.  However, there 
are some limitations to the clinical utility of the data from this important study.  The sample sizes 
are modest, comprising n=730 later born children with older probands with an ADHD diagnosis 
and n=158 later born children with older probands with an ASD diagnosis.  As a result, the 
confidence intervals of the elevated odds ratios reported are relatively wide (see Table 2) and this 
imprecision should add caution to how this information is conveyed to parents; though it is clear 
that the later born siblings are at considerably elevated likelihood of themselves going on to have 
ASD and ADHD.  Families with an older child who was typically developing but who subsequently 
had a child with ASD or ADHD and another younger child were removed from the control group, 
perhaps leading to slightly lower estimates of the likelihood of a subsequent diagnosis after a 
typically developing child.  One useful re-analysis of large population and registry databases4,5 – 
with larger population-representative samples – would be to separate out and report recurrence rates 
for later born siblings rather than all siblings (earlier and later born combined) in these studies and 
we encourage the authors of these studies to do this.  
 
Another set of different clinical issues also arise from these considerations.  One question pertains 
to when such information should be imparted to parents.  Often, parents seeking a diagnosis have 
known for some time that something is different about their child, and the developmental and 
behavioural difficulties their children are experiencing motivate the clinical consultation.  A 
diagnosis can help parents to recognise and understand some of the challenges their child is 
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experiencing and should provide a gateway to information and support services that can help 
families support their child and anticipate their needs.  Proactive monitoring of younger children for 
signs of ASD and ADHD could remove significant sources of stress in the process of seeking a 
diagnosis.  However, we suspect that there is wide variation in clinical practice in how information 
about the potential likelihood of another diagnosis in their younger child is presented.  It may not be 
best to impart this information at the initial feedback from the diagnostic consultation itself but at a 
later review meeting when parents have had the opportunity to find out more about ASD or ADHD 
and adjust to their new understanding of their child and family.  We expect that there is wide 
variance in how knowledgeable and confident clinicians feel about imparting information about the 
familial nature of neurodevelopmental conditions.  Whilst studies such as the present one will help 
to provide accessible and clinically translatable estimates of recurrence, more specialist training or 
even specialist genetic counselling services might have to be developed to provide this information 
to families sensitively and clearly, in the way that is increasingly the case for more monogenic 
forms of neurodevelopmental conditions7.  
 
The increasing recognition of within-child and within-family co-occurrence of neurodevelopmental 
conditions such as ASD and ADHD has also spurred developmental studies that aim to help us 
understand common and distinct mechanisms that lead to such outcomes.  Many studies over the 
past 15 years have prospectively studied infants with older siblings with ASD to identify the neural 
and developmental changes that fall on the causal path to later autism symptoms8,9.  Findings 
suggest that whilst overt behavioural differences are not consistently found until the second year of 
life, various neurodevelopmental differences may be present as early as six months of age that 
presage later emergent symptoms and the eventual development of an ASD clinical profile7,8.  
Similar studies of infants at familial increased likelihood of developing ADHD have been far fewer, 
although several are now underway6,10.  The present study suggests that the rates of an ADHD 
diagnosis in an infant with and older sibling with ADHD are similar to the rates of an ASD 
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diagnosis in an infant with an older sibling with ASD, making this design feasible.  More recently, 
such studies have begun to incorporate the increasing recognition that infants with older siblings 
with ASD may also be more likely to develop other neurodevelopmental conditions.  In other work, 
Miller, Iosif and colleagues11 have shown not only (consistent with the current paper) that by mid-
childhood rates of ADHD diagnosis are elevated in siblings with an older proband with ASD but 
also that in these individuals there is evidence of atypical visual attention from as early as the first 
six months of life.  We have recently examined infant predictors of mid-childhood ASD and ADHD 
traits in our own prospective study of younger siblings with probands with ASD12 and found that 
whilst increased activity levels of poor inhibitory control were associated with later ADHD traits 
they were not associated with later ASD traits, suggesting that early developmental pathways to 
ADHD might be distinct from ASD.  A recent study by Constantino and colleagues13 has found that 
at eighteen months of age traits of early ASD behaviours were both largely independent from those 
of early general psychopathology and that the former were highly heritable but the latter largely 
environmentally influenced.  They suggest that the widely observed co-occurrence of such traits 
later in childhood might operate from interactions over time between these independent 
susceptibilities.  Identification of the underlying mechanisms of co-occurrence between 
neurodevelopmental conditions such as ASD and ADHD is important not only to better understand 
aetiology but also to guide efforts towards targeted pre-emptive early intervention, examples of 
which have begun to emerge14,15. 
 
The current paper1 should be read by both the clinical and the research readership of the journal.  It 
utilises a simple and transparent design to report novel data on later born within- and cross-
condition recurrence of ASD and ADHD in a way that is utilisable in the clinic but also motivates 
research to understand how and why these conditions so commonly co-occur both within 
individuals and within families.  Future research should develop and test early, pre-emptive 
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interventions to ameliorate aspects of these neurodevelopmental conditions that can considerably 
challenge children and those who care for them. 
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